Links a CTD table-of-contents heading to the document(s) placed under it. Module 1 codes are regionally defined; Modules 2-5 are ICH-defined.
|
HA Controlled Vocabulary
Controlled Vocabulary / Code System Name as defoined by the Health Authority
|
Term
Term Description as defined by the Health Authority
|
Code
Code, if any, associated with the term by the Health Authority
|
Agency
Name of the issuing Health Authority (abbreviation) that maintains the term and code
|
Status
Current status of the Term usage as defined by the Health Authority (e.g., Current, Retired, Deprecated)
|
|---|---|---|---|---|
| US Context of Use | m1.16.2.6 rems modification history |
us_1.16.2.6
|
FDA | — |
| US Context of Use | m1.16.2.5 rems correspondence |
us_1.16.2.5
|
FDA | — |
| US Context of Use | m1.16.2.4 rems assessment methodology |
us_1.16.2.4
|
FDA | — |
| US Context of Use | m1.16.2.3 rems assessment |
us_1.16.2.3
|
FDA | — |
| US Context of Use | m1.16.2.2 draft rems |
us_1.16.2.2
|
FDA | — |
| US Context of Use | m1.16.2.1 final rems |
us_1.16.2.1
|
FDA | — |
| US Context of Use | m1.16.1 risk management (Non-REMS) |
us_1.16.1
|
FDA | — |
| US Context of Use | m1.15.2.1.4 annotated references |
us_1.15.2.1.4
|
FDA | — |
| US Context of Use | m1.15.2.1.3 annotated labeling version |
us_1.15.2.1.3
|
FDA | — |
| US Context of Use | m1.15.2.1.2 annotated version |
us_1.15.2.1.2
|
FDA | — |
| US Context of Use | m1.15.2.1.1 clean version |
us_1.15.2.1.1
|
FDA | — |
| US Context of Use | m1.15.1.9 withdrawal request |
us_1.15.1.9
|
FDA | — |
| US Context of Use | m1.15.1.8 correspondence accompanying materials previously missing or rejected |
us_1.15.1.8
|
FDA | — |
| US Context of Use | m1.15.1.7 response to information request |
us_1.15.1.7
|
FDA | — |
| US Context of Use | m1.15.1.6 response to untitled letter or warning letter |
us_1.15.1.6
|
FDA | — |
| US Context of Use | m1.15.1.5 pre dissemination review of televisions ads |
us_1.15.1.5
|
FDA | — |
| US Context of Use | m1.15.1.4 pre submission of non launch promotional materials for accelerated approval products |
us_1.15.1.4
|
FDA | — |
| US Context of Use | m1.15.1.3 pre submission of launch promotional materials for accelerated approval products |
us_1.15.1.3
|
FDA | — |
| US Context of Use | m1.15.1.2 request for advisory comments on non launch materials |
us_1.15.1.2
|
FDA | — |
| US Context of Use | m1.15.1.11 general correspondence |
us_1.15.1.11
|
FDA | — |
| US Context of Use | m1.15.1.10 submission of annotated references |
us_1.15.1.10
|
FDA | — |
| US Context of Use | m1.15.1.1 request for advisory comments on launch materials |
us_1.15.1.1
|
FDA | — |
| US Context of Use | m1.14.6 product labeling for 2253 submissions |
us_1.14.6
|
FDA | — |
| US Context of Use | m1.14.5 foreign labeling |
us_1.14.5
|
FDA | — |
| US Context of Use | m1.14.4.2 investigational drug labeling |
us_1.14.4.2
|
FDA | — |
Showing 276–300 of 380 terms . Data sourced from public health authority publications and updated periodically.